Tolerability and safety of urotainer® polihexanide 0.02% in catheterized patients: a prospective cohort study

by Jürgen Pannek, Karel Everaert, Sandra Möhr, Will Vance, Frank Van der Aa, Jürg Kesselring
Published 2020-07-01

Metabolic Changes after Urinary Diversion

by Frank Van der Aa, Steven Joniau, Marcel Van Den Branden, Hein Van Poppel
Published 2011-01-01

Excision and Primary Anastomosis for Bulbar Urethral Strictures Improves Functional Outcomes and Quality of Life: A Prospective Analysis from a Single Centre

by Pieter D’hulst, Michael S. Floyd, Fabio Castiglione, Kathy Vander Eeckt, Steven Joniau, Frank Van der Aa
Published 2019-01-01

A prospective randomized controlled multicentre trial comparing intravesical DMSO and chondroïtin sulphate 2% for painful bladder syndrome/interstitial cystitis

by Manuela Tutolo, Enrico Ammirati, Giulia Castagna, Katrien Klockaerts, Hendrik Plancke, Dieter Ost, Frank Van der Aa, Dirk De Ridder

Development of a Prospective Data Registry System for Non-muscle-Invasive Bladder Cancer Patients Incorporated in the Electronic Patient File System

by Murat Akand, Murat Akand, Tim Muilwijk, Jan Cornelissen, Siska Van Bruwaene, Kathy Vander Eeckt, Frederic Baekelandt, Pieter Mattelaer, Raf Van Reusel, Ben Van Cleynenbreugel, Steven Joniau, Frank Van Der Aa
Published 2019-12-01

Preclinical Targeted α- and β⁻-Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain Antibodies

by Janik Puttemans, Yana Dekempeneer, Jos L. Eersels, Heleen Hanssens, Pieterjan Debie, Marleen Keyaerts, Albert D. Windhorst, Frank van der Aa, Quentin Lecocq, Karine Breckpot, Alfred Morgenstern, Frank Bruchertseifer, Tony Lahoutte, Nick Devoogdt, Matthias D’Huyvetter
Published 2020-04-01